Combination Study of Prexasertib and Olaparib in Patients With Advanced Solid Tumors

Summary

This research study is studying a combination of targeted therapies as a possible treatment for Advanced Solid Tumors. The study interventions involved in this study are: * LY2606368 * Olaparib

Timeline

Start

2017-03-10

Primary completion

2020-02-25

Completion

2021-06-09

Publications

• Smith G, Alholm Z, Coleman RL, Monk BJ. DNA Damage Repair Inhibitors-Combination Therapies. Cancer J. 2021 Nov-Dec 01;27(6):501-505. doi: 10.1097/PPO.0000000000000561.

Drugs

Indications